BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7308165)

  • 1. [Value of calcitonin determination in the evaluation of completeness of thyroidectomy in medullary carcinoma of the thyroid gland].
    Wasylewski A; Skrzypek J; Kokot F; Sledziński Z
    Endokrynol Pol; 1981; 32(3):239-44. PubMed ID: 7308165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
    Horn J; Pfarr B; Ziegler R
    Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland].
    Krassowski J; Słowińska-Srzednicka J; Gietka M; Sawicki A; Kokot F; Zgliczyński S
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):757-9. PubMed ID: 2641802
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
    Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
    Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
    Goltzman D; Potts JT; Ridgway RC; Maloof F
    N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
    [No Abstract]   [Full Text] [Related]  

  • 6. Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay.
    Melvin KE; Miller HH; Tashjian AH
    N Engl J Med; 1971 Nov; 285(20):1115-20. PubMed ID: 5095737
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules.
    Giovanella L; Maffioli M; Suriano S; Dorizzi RM
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):852-3. PubMed ID: 19863575
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent results of reoperative surgery in medullary carcinoma of the thyroid.
    Tisell LE; Jansson S
    Wien Klin Wochenschr; 1988 May; 100(11):347-8. PubMed ID: 3407193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization and resection of clinically inapparent medullary carcinoma of the thyroid.
    Norton JA; Doppman JL; Brennan MF
    Surgery; 1980 Jun; 87(6):616-22. PubMed ID: 7376073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgery of thyroid cancer.
    Johnston ID
    Br J Surg; 1975 Oct; 62(10):765-8. PubMed ID: 1191935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA analysis and persistent hypercalcitoninemia in medullary thyroid carcinoma.
    Jeng TK; Lee CH; Wang HC; Chiu JW; Lui WY
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 May; 51(5):340-4. PubMed ID: 8334560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medullary thyroid carcinoma detected by serum calcitonin assay.
    Block MA; Jackson CE; Tashjian AH
    Arch Surg; 1972 Apr; 104(4):579-86. PubMed ID: 5013799
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of surgical results and prediction of prognosis in patients with medullary thyroid carcinoma by analysis of serum calcitonin levels.
    Miyauchi A; Matsuzuka F; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    World J Surg; 1988 Oct; 12(5):610-5. PubMed ID: 3245215
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical implications of medullary carcinoma of the thyroid.
    Watson AJ; Johnston ID
    Proc R Soc Med; 1970 Jun; 63(6):612-5. PubMed ID: 5453460
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma.
    Zink A; Blind E; Raue F
    Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin and carcino-embryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid.
    Palmer BV; Harmer CL; Shaw HJ
    Br J Surg; 1984 Feb; 71(2):101-4. PubMed ID: 6692098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
    Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
    Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endocrinological and clinicopathological studies on medullary thyroid carcinoma. Part 2: Biological behavior of the medullary thyroid carcinoma and its surgical implications (author's transl)].
    Obara T
    Nihon Gan Chiryo Gakkai Shi; 1977 Mar; 12(1):12-23. PubMed ID: 559026
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of medullary carcinoma of the thyroid.
    Simpson WJ; Palmer JA; Rosen IB; Mustard RA
    Am J Surg; 1982 Oct; 144(4):420-2. PubMed ID: 7125073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial medullary thyroid carcinoma.
    Hillyard CJ; Evans IM; Hill PA; Taylor S
    Lancet; 1978 May; 1(8072):1009-11. PubMed ID: 76933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.